Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians
about
Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.Consumer attitudes about opioid addiction treatment: a focus group study in New York City.The North American opioid epidemic: current challenges and a call for treatment as preventionHIV provider endorsement of primary care buprenorphine treatment: a vignette study.Buprenorphine treatment in an urban community health center: what to expectEffect of incarceration history on outcomes of primary care office-based buprenorphine/naloxoneIntegrating buprenorphine treatment into office-based practice: a qualitative studyImplementation science for the prevention and treatment of HIV/AIDS.A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions.Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.Hepatitis infection in the treatment of opioid dependence and abuse.Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review.Supply of buprenorphine waivered physicians: the influence of state policies.Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel ProcessBuprenorphine Prescribing Availability in a Sample of Ohio Specialty Treatment OrganizationsDiffusion of Newer HIV Prevention Innovations: Variable Practices of Frontline Infectious Diseases Physicians.Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphineGrowth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphineOffice-based management of opioid dependence with buprenorphine: clinical practices and barriersHome buprenorphine/naloxone induction in primary careA buprenorphine education and training program for primary care residents: implementation and evaluation.Inquiries about and initiation of buprenorphine treatment in an inner-city clinicAccess to substance use treatment among young adults who use prescription opioids non-medically.I heard about it from a friend: assessing interest in buprenorphine treatment.Barriers to primary care physicians prescribing buprenorphine.Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.The Time is Now: Improving Substance Abuse Training in Medical Schools.A mixed methods study of HIV-related services in buprenorphine treatment.Why aren't physicians prescribing more buprenorphine?"It's Never Just About the HIV:" HIV Primary Care Providers' Perception of Substance Use in the Era of "Universal" Antiretroviral Medication Treatment.Stigma associated with medication treatment for young adults with opioid use disorder: a case series.
P2860
Q31046185-216F05EC-7591-4996-BE5E-7959B5676A48Q33576948-F91F9F81-9BAC-47F5-A62C-BFD7F9DC2E2FQ33576957-566DC086-C999-4045-B796-8CA3834018B8Q33667492-803A8B30-3705-4EE2-95CF-3B170D62AE7DQ33685481-A06F8EBE-13BB-4AF1-9F67-815635684D76Q33735289-9ABA8EAB-5DC9-4F86-8B69-5E3D59965D82Q33898696-1C8DE662-002C-4CE2-A75A-E270858DAD8AQ34602077-2D3EEDD9-EE71-4458-864C-14C2E75441C2Q34678722-BF232B10-9112-4E2E-B6CA-3B1BE98A9BDDQ34850334-F553B167-8AC5-4959-9A19-0F6D8766482DQ35148360-376E7538-4C2E-48AD-80D4-7B1BC93EE29EQ35389163-95A209C6-F6BD-4E95-A850-FD3F3C57DDD9Q35400440-D7A1C889-D7E4-4404-BD59-E6380CA4C895Q35490468-8DA1400B-EECF-40E8-B460-2F8EDC2A5F33Q35491054-941F1299-14C9-4542-8F6E-E1C9704EFC00Q35571613-E063AD91-2146-4BE5-997B-0547A0A894C5Q35752218-A1B46CB2-B61C-4C33-9522-BABF84D364F8Q36058075-225EDA04-E9EB-4440-86B7-F18F2F043E02Q36369137-1E5809BE-FBD2-4CA1-9561-F542A17B0B0DQ36394777-DF2A5EF4-1911-4CC5-85FD-0DABCAB3C0F7Q36549928-B0257AD0-0973-4215-855B-199D71E4478CQ36821137-778EE661-561F-4CA3-A6BD-29B229078A69Q36841125-34FFB2BC-474A-4CDD-8A68-DCD8F656CEFBQ37067770-DA7ED390-E720-4E5A-9913-A771D97F2B84Q37237877-C9A746F3-AE03-46F9-B992-C9820A6D88C4Q37353120-F3192DF1-6A50-4C7F-9F74-489ECCE2C111Q37450263-AAAC6C95-CEBE-4219-81D4-818F76F5074CQ37617894-79A9CFDB-302A-48D6-8B8E-28185BE69BEDQ37628725-DB1EAC9B-9432-4BFA-B860-9A95A2034A55Q38244651-4CF049A6-CDEB-4085-8F84-404B07D81FFCQ38370171-BF09E5A6-A863-4A6A-91E0-2B0E21A2DE41Q38621655-1847D121-C49F-476A-83A1-0BB1B5E36DCAQ42024652-110643E8-A5E9-47EE-A515-4BE106274C1FQ47562198-1B65755E-9D4A-460A-92A1-D5C3FE2E6813Q55064583-115B4949-7290-4AEC-8693-BDCB1FCB6BDE
P2860
Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Barriers to obtaining waivers ...... treatment among HIV physicians
@ast
Barriers to obtaining waivers ...... treatment among HIV physicians
@en
type
label
Barriers to obtaining waivers ...... treatment among HIV physicians
@ast
Barriers to obtaining waivers ...... treatment among HIV physicians
@en
prefLabel
Barriers to obtaining waivers ...... treatment among HIV physicians
@ast
Barriers to obtaining waivers ...... treatment among HIV physicians
@en
P2093
P2860
P1476
Barriers to obtaining waivers ...... treatment among HIV physicians
@en
P2093
Hillary V Kunins
Nancy L Sohler
Rashiah T Elam
Robert J Roose
P2860
P2888
P304
P356
10.1007/S11606-007-0264-7
P577
2007-07-10T00:00:00Z